<SEC-DOCUMENT>0001140361-24-009506.txt : 20240226
<SEC-HEADER>0001140361-24-009506.hdr.sgml : 20240226
<ACCEPTANCE-DATETIME>20240226163750
ACCESSION NUMBER:		0001140361-24-009506
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240226
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240226
DATE AS OF CHANGE:		20240226

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKET PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001281895
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36829
		FILM NUMBER:		24679564

	BUSINESS ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		646-440-9100

	MAIL ADDRESS:	
		STREET 1:		350 FIFTH AVENUE
		STREET 2:		SUITE 7530
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INOTEK PHARMACEUTICALS CORP
		DATE OF NAME CHANGE:	20040226
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20022436_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:rckt="http://rocketpharma.com/20240226" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.2.1.5221
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_668b7a7818be490283c01076eb292eb4" contextRef="c20240226to20240226" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_dc9e31b701264729885dc8a924585360" contextRef="c20240226to20240226">0001281895</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_222f222ba04242a38790efa9ebe5cb02" contextRef="c20240226to20240226">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="rckt-20240226.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240226to20240226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001281895</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-26</xbrli:startDate><xbrli:endDate>2024-02-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, DC 20549</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_4c4279f67cb34e128bd426427e9083c7" contextRef="c20240226to20240226">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_b3a045cd3b2a4930b64a60fcd1e17a30" contextRef="c20240226to20240226" format="ixt:date-monthname-day-year-en">February 26, 2024</ix:nonNumeric></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-size: 10pt;"><br/>
        </span></div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_12b86a98272140c88cfa341b1f298cef" contextRef="c20240226to20240226">Rocket Pharmaceuticals, Inc.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div><span style="font-size: 10pt;"><br/>
      </span></div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div> <span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.3%; vertical-align: middle; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_8a742937a4fd4f16bf8275042d601257" contextRef="c20240226to20240226" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
            </td>

    <td style="width: 34%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_aa4afec69cd94eedbe8992956283188a" contextRef="c20240226to20240226">001-36829</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 32.7%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_eacc1091cfb54973a6f4f7731a1df3af" contextRef="c20240226to20240226">04-3475813</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Commission File Number)</div>
            </td>

    <td style="width: 32.7%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div> <span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_fd4d6d6bd53d430fb3aee8169200b8ca" contextRef="c20240226to20240226">9 Cedarbrook Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_782531a4e24a4f09916596c528732aac" contextRef="c20240226to20240226">Cranbury</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_03cc1956ea514e609294fbf9e1839539" contextRef="c20240226to20240226">NJ</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_b281b363aa3e4c92888673cfc2f5b62a" contextRef="c20240226to20240226">08512</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: top;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">(</span><span style="font-size: 10pt;">Address of principal
                  executive offices)</span></div>
            </td>

    <td style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div> <span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; font-size: 10pt;">Registrant&#8217;s telephone number, including area code:&#160; (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_e71fbc96dd10407ba0e3d78f3264713b" contextRef="c20240226to20240226">646</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_fa78eb98e518459fa8649f74dcbe5918" contextRef="c20240226to20240226">440-9100</ix:nonNumeric></div>

      <div style="text-align: center; font-size: 10pt;"> <span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center;"> <span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">Not applicable</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions (see General Instruction A.2):</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_15a1d46810d8468e9f9ad08849d24b48" contextRef="c20240226to20240226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_6e4cb2417b024ab3b69d9e815bce83b4" contextRef="c20240226to20240226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_71ccfc58638e4570b1e1aa2028abb5b7" contextRef="c20240226to20240226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; text-indent: -18pt; margin-left: 18pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_cafd594c284f4c4997cc750133cafdb0" contextRef="c20240226to20240226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of each class</div>
            </td>

    <td style="width: 34%; vertical-align: middle;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Trading</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Symbol(s)</div>
            </td>

    <td style="width: 33%; vertical-align: middle;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name of each exchange on which</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_f3cec55317fb4c7696da75b236b1d582" contextRef="c20240226to20240226">Common stock, $0.01 par value</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_c486cf3ceed94f2e9a37a81d8064329c" contextRef="c20240226to20240226">RCKT</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: middle; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="-sec-ix-hidden:Fact_222f222ba04242a38790efa9ebe5cb02">The Nasdaq Global Market</span><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: right; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_0a66415bdcbc4a68a28a151075bf9ea9" contextRef="c20240226to20240226" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';"><br/>
        </span></div>

      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.02.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Results of Operations and Financial Condition.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On February 26, 2024, Rocket Pharmaceuticals, Inc. (the &#8220;Company&#8221;) <span style="font-family: 'Times New Roman';">announced certain
          financial results for the quarter and full year ended December 31, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed &#8220;filed&#8221; for
        purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the
        Exchange Act, except as expressly set forth by specific reference in such filing.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 3.85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(d)</div>
            </td>

    <td style="width: 96.15%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><a href="ef20022436_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 95%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release of Rocket Pharmaceuticals, Inc. dated February 26, 2024.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 95%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; text-indent: 20pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
        behalf by the undersigned hereunto duly authorized.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.91%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="width: 50.09%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 46.88%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date: February 26, 2024</div>
            </td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
            </td>

    <td style="width: 46.88%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Martin Wilson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 46.88%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Martin Wilson</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.91%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 3.21%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 46.88%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-style: italic;">General Counsel and Chief Compliance Officer, SVP</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left;">
<div><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span></div>

        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20022436_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 24.2.1.5221
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 99.1<br>
        </font></div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; margin-left: 9pt;">
        <div style="text-align: left;"><img src="image00003.jpg"></div>
        <div style="text-align: center;"> <br>
          Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress</div>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Advancing leading pipeline of six disclosed programs across AAV cardiovascular and LV hematology portfolios; all milestones remain on track for 2024</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Expanding commercial capabilities to support launch of LV portfolio beginning with KRESLADI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup> (marnetegragene autotemcel) for severe
        LAD-I; PDUFA date of June 30, 2024</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Cash, cash equivalents and investments of approximately $407.5M; expected operational runway into 2026</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">CRANBURY, N.J. </font><font style="font-size: 10pt;">&#8211; <font style="font-family: 'Times New Roman'; font-weight: bold;">Feb. 26, 2024 </font>&#8211; <u><font style="font-family: 'Times New Roman';">Rocket Pharmaceuticals, Inc.</font></u> (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a
          sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and operational results for the fourth quarter and year ended December 31, 2023.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;I am pleased with the strong results Rocket delivered in 2023, as we closed another successful year of progress across all six disclosed gene therapy programs spanning
        our AAV cardiovascular and LV hematology portfolios,&#8221; said Gaurav Shah, M.D., Chief Executive Officer, Rocket Pharma. &#8220;We are well poised to make further strides in 2024, notably expanding our commercial and operational capabilities to support the
        anticipated launch of KRESLADI&#8482; (marnetegragene autotemcel) for severe LAD-I, representing Rocket&#8217;s first step in making our gene therapies available to patients who need them most. At the same time, we are laser focused on regulatory filings in
        Fanconi Anemia and continuing to advance our clinical programs in Danon Disease, PKP2-ACM and PKD in the year ahead. As we close the quarter, Rocket continues to solidify our industry leadership in gene therapy across multiple therapeutic areas and
        platforms as we seek to meet the needs of patients living with rare and devastating diseases.&#8221;</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Recent Pipeline and Operational Updates</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z24a238df36ce49e0911d43cd000b26e9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Milestones remain on track for 2024 across pipeline of adeno-associated virus (AAV) cardiovascular
                  and lentiviral (LV) vector hematology portfolios. </font><font style="font-size: 10pt;">The Marketing Authorisation Application (MAA) and Biologics License Application (BLA) for Fanconi Anemia remain on track for filing with the European
                  Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA), respectively, in the first half of 2024. Rocket is also progressing its Phase 2 pivotal study of RP-A501 for Danon Disease, Phase 2 pivotal study of RP-L301 for Pyruvate
                  Kinase Deficiency (PKD), Phase 1 study of RP-A601 for PKP2-<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">a</font>rrhythmogenic cardiomyopathy<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> (ACM)</font>,
                  and IND-enabling studies for BAG3-associated dilated cardiomyopathy (DCM).</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div> <img src="image00003.jpg"></div>
        <div> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="z13570d4fda874b409558deaeb42fc30f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: left;">
                <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">KRESLADI</font><font style="font-size: 10pt;"><sup style="font-weight: bold; vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup><font style="font-family: 'Times New Roman'; font-weight: bold;"> for severe Leukocyte Adhesion Deficiency-I (LAD-I) on track for PDUFA date of June 30, 2024</font>.<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>Based





                    on the positive top-line efficacy and safety data from the global Phase 1/2 study and high unmet need in patients with severe LAD-I, the FDA accepted the BLA and granted Priority Review for KRESLADI<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">TM</sup>. On February 13, 2024,
                    Rocket announced the FDA extended the Priority Review period by three months, to June 30, 2024, to allow additional time to review clarifying Chemistry, Manufacturing, and Controls (CMC) information submitted by Rocket in response to
                    FDA information requests. The FDA further confirmed that an advisory committee meeting is not needed. In support of its first product launch, Rocket continues to expand its commercial and operational infrastructure, including Qualified
                    Treatment Center initiation, channel strategy, disease education, and payer engagement.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z87a532bad89c4269a9f6b1e5a9e40532" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Published data from preclinical study of RP-A601 in PKP2-ACM. </font><font style="font-size: 10pt;">&#8220;AAV-Mediated Delivery of Plakophilin-2a Arrests Progression of Arrhythmogenic Right Ventricular Cardiomyopathy in Murine Hearts: Preclinical Evidence Supporting Gene Therapy in Humans&#8221; was published in <font style="font-family: 'Times New Roman'; font-style: italic;">Circulation: Genomic and Precision Medicine. </font>Results from the study demonstrated the potential of RP-A601 as a gene therapy for patients with PKP2-ACM.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z2da7c9a3180d4906bb1782bf12a2a5cc" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Bolstered commercial and operational expertise of Board of Directors with appointment of R. Keith
                  Woods.</font><font style="font-size: 10pt;"> Mr. Woods is a seasoned executive with more than 30 years of experience spanning commercialization, global operations, business strategy and supply chain. He recently served as Chief Operating
                  Officer of argenx, where he led its global commercial organization, including marketing, market access, medical affairs, program management, and supply chain, during the company&#8217;s successful transition to commercial stage. Mr. Woods
                  launched Vyvgart, a treatment for a rare autoimmune condition that causes muscle weakness, generating more than $1 billion in sales.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Upcoming Investor Conferences</div>
      <table cellspacing="0" cellpadding="0" id="zfe8ccc7c0e2a43fd80074392c83dde20" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Cowen&#8217;s 44th Annual Health Care Conference: March 5, 2024</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="ze26ad32470af41e096126be4778178ef" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Leerink Partners Global Biopharma Conference: March 12, 2024</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z336fc733f13b48c58acd8ced882e145b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Needham 23rd Annual Virtual Healthcare Conference: April 9, 2024</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Fourth Quarter and Full Year 2023 Financial Results</div>
      <table cellspacing="0" cellpadding="0" id="zadf684eac83f43f2834b32ee788f1872" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash position</font><font style="font-size: 10pt;">. Cash, cash equivalents and investments as of
                  December 31, 2023, were $407.5 million.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zf342b81576ca49499fe9ea3d8ba9de25" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">R&amp;D expenses</font><font style="font-size: 10pt;">. Research and development expenses were
                  $41.7 million and $186.3 million for the three and twelve months ended December 31, 2023, respectively, compared to $50.0 million and $165.6 million for the three and twelve months ended December 31, 2022, respectively. The increase in
                  R&amp;D expenses for the twelve months ended December 31, 2023, was primarily driven by increased compensation and benefits expense of $16.9 million due to increased R&amp;D headcount, increased clinical trial costs of $14.5 million, and
                  increased non-cash stock compensation expense of $5.0 million, offset by a decrease in manufacturing and development costs of $17.0 million.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="zd2872fc195d44436a960556f5f743050" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">G&amp;A expenses</font><font style="font-size: 10pt;">. General and administrative expenses were
                  $21.5 million and $73.3 million for the three and twelve months ended December 31, 2023, respectively, compared to $19.0 million and $58.8 million for the three and twelve months ended December 31, 2022, respectively. The increase in
                  G&amp;A expenses for the twelve months ended December 31, 2023, was primarily driven by increases in commercial preparation expenses which consists of commercial strategy, medical affairs, market development and pricing analysis of $8.4
                  million and increased non-cash stock compensation expense of $3.4 million.</font></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div> <img src="image00003.jpg"></div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z9392a6f5e9a24a66913f01b81a329028" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Net loss</font><font style="font-size: 10pt;">. Net loss was $59.7 million and $245.6 million or
                  $0.64 and $2.92 per share (basic and diluted) for the three and twelve months ended December 31, 2023, compared to $66.7 million and $221.9 million or $0.92 and $3.26 per share (basic and diluted) for the three and twelve months ended
                  December 31, 2022.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" id="z0cc8b9004392448fb5560616712ba21a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Shares outstanding</font><font style="font-size: 10pt;">. 90,282,267 shares of common stock were
                  outstanding as of December 31, 2023.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">Financial Guidance</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;"> <br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z0f8319239395486ea0aed1145a765c55" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left;">
              <div style="font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Cash position. </font><font style="font-size: 10pt;">As of December 31, 2023, Rocket had cash,
                  cash equivalents and investments of $407.5 million. Rocket expects such resources will be sufficient to fund its operations into 2026, including producing AAV<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>cGMP
                  batches at the Company&#8217;s Cranbury, N.J. R&amp;D and manufacturing facility and continued development of its six clinical and/or preclinical programs.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Rocket Pharmaceuticals, Inc.</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic
          therapies designed to correct the root cause of complex and rare disorders. Rocket&#8217;s innovative multi-platform approach allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable
          people living with devastating rare diseases to experience long and full lives.</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Rocket&#8217;s lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia , a difficult to treat genetic
          disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase
          Deficiency (PKD), a monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia.</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Our adeno-associated virus (AAV)-based cardiovascular portfolio includes a late-stage program for Danon Disease, a devastating heart failure condition resulting in
          thickening of the heart, an early-stage program in clinical trials for PKP2-<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">a</font>rrhythmogenic cardiomyopathy<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">
            (ACM), a life-threatening heart failure disease causing </font>ventricular arrhythmias and sudden cardiac death, and a pre-clinical program targeting BAG3-associated dilated cardiomyopathy (DCM), a heart failure condition that causes enlarged
          ventricles.</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For more information about Rocket, please visit <u><font style="font-family: 'Times New Roman';">www.rocketpharma.com</font></u> and follow us on <u><font style="font-family: 'Times New Roman';">LinkedIn</font></u>, <u><font style="font-family: 'Times New Roman';">YouTube</font></u> and <u><font style="font-family: 'Times New Roman';">X</font></u>.</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <img src="image00003.jpg"></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Rocket Cautionary Statement Regarding Forward-Looking Statements</div>
      <div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This press release contains forward-looking statements concerning Rocket&#8217;s future expectations, plans and prospects that involve risks and uncertainties, as well as
          assumptions that, if they do not materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. We make such forward-looking statements pursuant to the safe harbor
          provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. All statements other than statements of historical facts contained in this release are forward-looking statements. You should not place reliance
          on these forward-looking statements, which often include words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will give,&#8221; &#8220;estimate,&#8221; &#8220;seek,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;suggest&#8221; or similar terms, variations of such terms or the negative of
          those terms. These forward-looking statements include, but are not limited to, statements concerning Rocket&#8217;s expectations regarding the safety and effectiveness of product candidates that Rocket is developing to treat Fanconi Anemia (FA),
          Leukocyte Adhesion Deficiency-I (LAD-I), Pyruvate Kinase Deficiency (PKD), Danon Disease (DD) and other diseases, the expected timing and data readouts of Rocket&#8217;s ongoing and planned clinical trials, the expected timing and outcome of Rocket&#8217;s
          regulatory interactions and planned submissions, Rocket&#8217;s plans for the advancement of its DD program, including its planned pivotal trial, and the safety, effectiveness and timing of related pre-clinical studies and clinical trials, Rocket&#8217;s
          ability to establish key collaborations and vendor relationships for its product candidates, Rocket&#8217;s ability to develop sales and marketing capabilities or enter into agreements with third parties to sell and market its product candidates and
          Rocket&#8217;s ability to expand its pipeline to target additional indications that are compatible with its gene therapy technologies. Although Rocket believes that the expectations reflected in the forward-looking statements are reasonable, Rocket
          cannot guarantee such outcomes. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, Rocket&#8217;s dependence on third parties for
          development, manufacture, marketing, sales and distribution of product candidates, the outcome of litigation, unexpected expenditures, Rocket&#8217;s competitors&#8217; activities, including decisions as to the timing of competing product launches, pricing
          and discounting, Rocket&#8217;s ability to develop, acquire and advance product candidates into, enroll a sufficient number of patients into, and successfully complete, clinical studies, Rocket&#8217;s ability to acquire additional businesses, form strategic
          alliances or create joint ventures and its ability to realize the benefit of such acquisitions, alliances or joint ventures, Rocket&#8217;s ability to obtain and enforce patents to protect its product candidates, and its ability to successfully defend
          against unforeseen third-party infringement claims, as well as those risks more fully discussed in the section entitled &#8220;Risk Factors&#8221; in Rocket&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, filed February 28, 2023 with the
          SEC and subsequent filings with the SEC including our Quarterly Reports on Form 10-Q.&#160; Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and Rocket undertakes
          no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="font-size: 10pt;"><img src="image00003.jpg"></div>
        <div style="text-align: left; font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" class="cfttable" id="zafb0f65ec18141bbb25f10beed726c64" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Three Months Ended December 31,</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="6" style="vertical-align: bottom;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Twelve Months Ended December 31,</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> 2023</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2023</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;">
                  <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2022</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Operating expenses:</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">Research and development</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">41,744</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">50,037</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">186,342</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">165,570</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 18pt;">General and administrative</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">21,535</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">19,044</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">73,317</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">58,773</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 27pt;">Total operating expenses</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">63,279</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">69,081</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">259,659</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">224,343</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Loss from operations</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(63,279</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(69,081</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(259,659</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(224,343</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Research and development incentives</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">500</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">-</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">500</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Interest expense</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(470</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(467</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(1,875</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(1,862</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Interest and other income, net</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">814</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,245</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">5,288</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,889</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; padding-bottom: 2px;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Accretion of discount and amortization of premium on investments, net</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">3,275</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">1,081</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">10,651</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(47</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Net loss</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(59,660</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(66,722</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(245,595</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(221,863</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; padding-bottom: 4px;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Net loss per share - basic and diluted</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(0.64</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(0.92</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(2.92</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">(3.26</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div>
                </td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Weighted-average common shares outstanding - basic and diluted</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">93,336,541</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">72,889,548</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">84,009,004</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">68,148,925</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: bottom;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">December 31,</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; padding-bottom: 2px; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">&#160;</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftcurrcell" colspan="2" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2023</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: center; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; text-align: center;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" rowspan="1" class="cftcurrcell" colspan="2" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; text-align: center;">2022</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 2px;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Cash, cash equivalents, and investments</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">407,495</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">399,670</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total assets</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">566,341</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">551,807</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total liabilities</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">73,767</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">62,121</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
              </tr>
              <tr>
                <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 52%;">
                  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; text-indent: -9pt; margin-left: 9pt;">Total stockholders&#8217; equity</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">492,574</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
                  <div style="font-family: 'Times New Roman'; font-size: 10pt;">489,686</div>
                </td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
                <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
              </tr>

          </table>
        </div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Media</div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Kevin Giordano</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><u>media@rocketpharma.com</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investors</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Brooks Rahmer</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>investors@rocketpharma.com</u></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rckt-20240226.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.2.1.5221 Broadridge-->
<xs:schema targetNamespace="http://rocketpharma.com/20240226" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:rckt="http://rocketpharma.com/20240226" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20240226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="rckt-20240226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rckt-20240226_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.2.1.5221 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rckt-20240226_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.2.1.5221 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://rocketpharma.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="rckt-20240226.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://rocketpharma.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00003.jpg
<TEXT>
begin 644 image00003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !7 +P# 2(  A$! Q$!_\0
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MO^O,S*]]_9Y_Y%?4O^OS_P!D6O*_!_@;6?%$BM:0>39YPUU,,)^'=C]*^AO
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9BB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139701344617120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 26,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Rocket Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001281895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3475813<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9 Cedarbrook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">440-9100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RCKT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( +:$6E@D'INBK0   /@!   :
M          "  <@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( +:$6EAED'F2&0$  ,\#   3              "  :T2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20022436_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rocketpharma.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20022436_8k.htm">ef20022436_8k.htm</File>
    <File>rckt-20240226.xsd</File>
    <File>rckt-20240226_lab.xml</File>
    <File>rckt-20240226_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20022436_8k.htm": {
   "nsprefix": "rckt",
   "nsuri": "http://rocketpharma.com/20240226",
   "dts": {
    "inline": {
     "local": [
      "ef20022436_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "rckt-20240226.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rckt-20240226_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rckt-20240226_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://rocketpharma.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240226to20240226",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20022436_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240226to20240226",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20022436_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://rocketpharma.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-24-009506-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-009506-xbrl.zip
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MPH\Z5!V\)O97F4I@=W=+NUO>";K*Q6#*C)IS3!ZT4%X%2SR,:(9NOR$6Z*2
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MT+XILV:A8L!, >8CD8H!$D$&AZ )7$2('VR!(X,1IP/)S1[22R\H]Z7. N5
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MHT$ =L31 \ 10=\JGX@7UD<  2P'OW&RA&\%8V0.],PB3&D6Q4-> ?K"2X)
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M(X&B7"*]995^: $C9G@^,!/"U1F)_!0449>#(DKF@KX@XLD64!  XH2_7",
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M\I4,P9JX>$4O);> 9.66G)B5+U:RDE<7]R[SB72;RT%;850.C_S,Q;' <\S
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M6N?/"O+G.?+E[9$6SDFDUBBRM\9D]?OQGI668OBFSV+[R^RUB#DR?VVJQ73
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M#&7NU3N1#0^)@I61'7SE)>GU>I&+KJ!&B!V19EQIPBG4\=G:>1U\$95!#\V
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MCV?O_Y9#9O[&=-]J;<0]CDJQZS]02P,$%     @ MH1:6-] &L1Z"   ,%8
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M\C',X)MSHU):1!JE\^(QCL!]T>C<FQ<+W$LL$F%%E1G5]CZL"W,]B77BH74
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MB&\0?S_?1<2+^+OVA_\!4$L! A0#%     @ MH1:6*3%MGA2$@  $7@  !$
M             ( !     &5F,C P,C(T,S9?.&LN:'1M4$L! A0#%     @
MMH1:6"D@;?%6(@  >I,! !4              ( !@1(  &5F,C P,C(T,S9?
M97@Y.2TQ+FAT;5!+ 0(4 Q0    ( +:$6EBK6UFL2 ,  $4/   1
M      "  0HU  !R8VMT+3(P,C0P,C(V+GAS9%!+ 0(4 Q0    ( +:$6EC?
M0!K$>@@  #!6   5              "  8$X  !R8VMT+3(P,C0P,C(V7VQA
M8BYX;6Q02P$"% ,4    " "VA%I8VD3=%-\%  #Y/@  %0
M@ $N00  <F-K="TR,#(T,#(R-E]P<F4N>&UL4$L%!@     %  4 1P$  $!'
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ef20022436_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rckt-20240226.xsd" xlink:type="simple"/>
    <context id="c20240226to20240226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001281895</identifier>
        </entity>
        <period>
            <startDate>2024-02-26</startDate>
            <endDate>2024-02-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240226to20240226"
      id="Fact_668b7a7818be490283c01076eb292eb4">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20240226to20240226"
      id="Fact_dc9e31b701264729885dc8a924585360">0001281895</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20240226to20240226"
      id="Fact_222f222ba04242a38790efa9ebe5cb02">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20240226to20240226"
      id="Fact_4c4279f67cb34e128bd426427e9083c7">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240226to20240226"
      id="Fact_b3a045cd3b2a4930b64a60fcd1e17a30">2024-02-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20240226to20240226"
      id="Fact_12b86a98272140c88cfa341b1f298cef">Rocket Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240226to20240226"
      id="Fact_8a742937a4fd4f16bf8275042d601257">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240226to20240226"
      id="Fact_aa4afec69cd94eedbe8992956283188a">001-36829</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240226to20240226"
      id="Fact_eacc1091cfb54973a6f4f7731a1df3af">04-3475813</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240226to20240226"
      id="Fact_fd4d6d6bd53d430fb3aee8169200b8ca">9 Cedarbrook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20240226to20240226"
      id="Fact_782531a4e24a4f09916596c528732aac">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20240226to20240226"
      id="Fact_03cc1956ea514e609294fbf9e1839539">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240226to20240226"
      id="Fact_b281b363aa3e4c92888673cfc2f5b62a">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20240226to20240226"
      id="Fact_e71fbc96dd10407ba0e3d78f3264713b">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240226to20240226"
      id="Fact_fa78eb98e518459fa8649f74dcbe5918">440-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20240226to20240226"
      id="Fact_15a1d46810d8468e9f9ad08849d24b48">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240226to20240226"
      id="Fact_6e4cb2417b024ab3b69d9e815bce83b4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240226to20240226"
      id="Fact_71ccfc58638e4570b1e1aa2028abb5b7">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240226to20240226"
      id="Fact_cafd594c284f4c4997cc750133cafdb0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240226to20240226"
      id="Fact_f3cec55317fb4c7696da75b236b1d582">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240226to20240226"
      id="Fact_c486cf3ceed94f2e9a37a81d8064329c">RCKT</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240226to20240226"
      id="Fact_0a66415bdcbc4a68a28a151075bf9ea9">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
